[-] Show simple item record

dc.contributor.authorFleming, David A.eng
dc.contributor.otherUniversity of Missouri-Columbia. School of Medicine. Department of Health Management and Informatics. Center for Health Ethicseng
dc.date.issued2004-10eng
dc.descriptionEssayeng
dc.description.abstractThe practice of medicine requires clinical judgments within the context of an inexact and very complicated science, the end result of which has profound implication for the welfare of patients. The ethical question for the practitioner is whether changing medications for the sake of research or other interests outside the patient can be justified for the sake of those interests, as long as the patient is at low risk for being harmed. My response to this question is that any clinical decision is ethically defensible only if it is reasonable to think that such a move is in the best interest of the patient, all other interests remaining secondary.eng
dc.identifier.urihttp://hdl.handle.net/10355/2901eng
dc.publisherCenter for Health Ethicseng
dc.relation.ispartofCenter for Health Ethics publicationseng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Health Management and Informatics. Center for Health Ethicseng
dc.relation.ispartofseriesEthical Issues Series;Oct. 2004eng
dc.subject.lcshClinical trialseng
dc.subject.lcshExperimental pharmacology -- Moral and ethical aspectseng
dc.titleThe Ethical Use of New Drugseng
dc.typeOthereng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record